FDA Drug Recalls

Recalls / Class II

Class IID-1408-2014

Product

Dextroamphetamine Sulfate Tablets, USP, 10 mg, 100-count bottles, Rx only, Barr Laboratories, Inc., Pomona, NY 10970, NDC 0555-0953-02.

Brand name
Dextroamphetamine Sulfate
Generic name
Dextroamphetamine Sulfate
Active ingredient
Dextroamphetamine Sulfate
Route
Oral
NDCs
0555-0952, 0555-0953
FDA application
ANDA040361
Affected lot / code info
Lot # 34013122A, Exp 11/15

Why it was recalled

Failed Impurities/Degradation Specifications: this product is being recalled due to an out of specification test result for impurities during stability testing.

Recalling firm

Firm
Teva Pharmaceuticals USA
Manufacturer
Teva Pharmaceuticals USA, Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
425 Privet Rd, N/A, Horsham, Pennsylvania 19044-1220

Distribution

Quantity
9,882 bottles
Distribution pattern
Nationwide and Puerto Rico

Timeline

Recall initiated
2014-05-01
FDA classified
2014-06-23
Posted by FDA
2014-07-02
Terminated
2014-12-09
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-1408-2014. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.